MOLECULAR ANGIOPLASTY
USPTO Trademark Record · Serial No. 75545841
Trademark details
It was initially claimed by Esperion Therapeutics, Inc. on 19980901.
That brand applies to the following goods and services:Pharmaceutical products, namely intravenously administered recombinant- protein, alone or in association with unilamellar vessicles to promote lipid transport in the treatment of atherosclerosis and its associated complications.
Currently that trademark is represented by trademark attorney(s): SCOTT E TAYLOR.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the MOLECULAR ANGIOPLASTY trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
